| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |